Pharmacogenetic profiling and clinical outcome of patients (pts) with advanced gastric cancer (AGC) treated with S-1 monotherapy

被引：0
|
作者：
Ichikawa, W. [1 ]
Takahashi, T. [1 ]
Sasaki, Y. [1 ]
机构：
[1] Saitama Med Sch, Iruma, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4600
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy
    Ruzzo, A
    Graziano, F
    Kawakami, K
    Watanabe, G
    Santini, D
    Catalano, V
    Bisonni, R
    Canestrari, E
    Ficarelli, R
    Menichetti, ET
    Mari, D
    Testa, E
    Silva, R
    Vincenzi, B
    Giordani, P
    Cascinu, S
    Giustini, L
    Tonini, G
    Magnani, M
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1883 - 1891
  • [2] Phase I/II study of docetaxel (DOC) and S-1 for patients (pts) with advanced gastric cancer (AGC).
    Hyodo, I
    Yamaguchi, K
    Koizumi, W
    Narahara, H
    Kato, T
    Akiya, T
    Sakata, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 323S - 323S
  • [3] S-1 monotherapy for the treatment of elderly patients with advanced gastric cancer
    Lim, J.
    Kim, J.
    Yi, H.
    Kim, H.
    Lee, M.
    Kim, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Pharmacokinetics (PK) of S-1 monotherapy in plasma and in tears for gastric cancer patients (pts).
    Kawakami, Takeshi
    Kashiwagi, Hiroya
    Mori, Keita
    Omae, Katsuhiro
    Kasai, Jun
    Yoshisue, Kunihiro
    Kawahira, Masahiro
    Tsushima, Takahiro
    Machida, Nozomu
    Fukutomi, Akira
    Yamaguchi, Ken
    Yasui, Hirofumi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [5] Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
    Ming-ming He
    Dong-sheng Zhang
    Feng Wang
    Zi-xian Wang
    Shu-qiang Yuan
    Zhi-qiang Wang
    Hui-yan Luo
    Chao Ren
    Miao-zhen Qiu
    Ying Jin
    De-shen Wang
    Dong-liang Chen
    Zhao-lei Zeng
    Yu-hong Li
    Yang-yang He
    Yuan-tao Hao
    Pi Guo
    Feng-hua Wang
    Yi-xin Zeng
    Rui-hua Xu
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 69 - 79
  • [6] Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
    He, Ming-ming
    Zhang, Dong-sheng
    Wang, Feng
    Wang, Zi-xian
    Yuan, Shu-qiang
    Wang, Zhi-qiang
    Luo, Hui-yan
    Ren, Chao
    Qiu, Miao-zhen
    Jin, Ying
    Wang, De-shen
    Chen, Dong-liang
    Zeng, Zhao-lei
    Li, Yu-hong
    He, Yang-yang
    Hao, Yuan-tao
    Guo, Pi
    Wang, Feng-hua
    Zeng, Yi-xin
    Xu, Rui-hua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 69 - 79
  • [7] Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
    Xu, R.
    Zeng, Y.
    He, M. -M.
    Zhang, D.
    Wang, F.
    ANNALS OF ONCOLOGY, 2015, 26 : 61 - 61
  • [8] Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
    He, Ming-ming
    Xu, Rui-hua
    Zhang, Dong-sheng
    Wang, Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer
    Tsushima, Takahiro
    Hironaka, Shuichi
    Boku, Narikazu
    Machida, Nozomu
    Yamazaki, Kentaro
    Yasui, Hirofumi
    Taku, Keisei
    Fukutomi, Akira
    Onozawa, Yusuke
    GASTRIC CANCER, 2010, 13 (04) : 245 - 250
  • [10] Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer
    Takahiro Tsushima
    Shuichi Hironaka
    Narikazu Boku
    Nozomu Machida
    Kentaro Yamazaki
    Hirofumi Yasui
    Keisei Taku
    Akira Fukutomi
    Yusuke Onozawa
    Gastric Cancer, 2010, 13 : 245 - 250
12345